Fullerton Fund Management CO Ltd. Novo Nordisk A S Transaction History

Fullerton Fund Management CO Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $266,176 - $336,172	-3,153 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $119,149 - $149,262	-1,761 Reduced 35.84%	3,153 $264,000
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $96,834 - $109,484	-1,444 Reduced 22.71%	4,914 $331,000
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $236,073 - $272,691	3,695 Added 138.75%	6,358 $444,000
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $169,606 - $186,995	2,663 New	2,663 $185,000

1,861

322M

5.49M

7.77M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $195B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Fullerton Fund Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Fullerton Fund Management CO Ltd. with notifications on news.